Skip to main content

Military Health System

Army’s 773rd administers mobile COVID-19 testing during DEF21

Image of Three military personnel, wearing masks and lab coats, pose for a picture in an Albanian lab. Three members of the laboratory COVID-19 testing team (left) Army Capt. Fawn OLeary, medical service officer, (middle) Army Capt. So, chemical officer and (right) Army Maj. Brooke Spridgen, lab officer, assigned to 773rd Civil Support Team, 7th Mission Support Command, take a well deserved break while administering COVID-19 testing during DEFENDER-Europe 21 at Kucove, Albania in May 2021. (Photo by Army Staff Sgt. Thomas Mort.)

Recommended Content:

Health Readiness & Combat Support | Coronavirus & the MHS Response | Coronavirus and the COVID-19 Vaccine | Readiness Capabilities

A five-member laboratory COVID-19 testing team assigned to the Army’s 773rd Civil Support Team, 7th Mission Support Command, administer COVID-19 testing for unit movement throughout Albania, from April through early June 2021.

“We were the first ones to arrive and have been out here testing all of the units coming to Albania,” said Army Maj. Brooke Spridgen, lab officer, 773rd Civil Support Team, 7th Mission Support Command. “We also tested a large unit, the 7th TBX (a transportation brigade out of Fort Eustis, Virginia) of approximately 600,” added Spridgen.

The five Soldier team is the only COVID-19 testing capable unit outside of Germany, during DEFENDER 21.

“We can do same day testing for those here in Albania so they can get released from ROM [restriction of movement] quicker in order to start their mission,'' explains Spridgen. “Otherwise it's collected then has to be shipped back to Germany…. and go through customs and public health command.”

Once samples are tested and documented on a spreadsheet, the ISOFAC team and the unit's provider are notified. The team of five will complete about 3,000 tests during their DEFENDER 21 mission.

They work closely with the Isolation Facility Team (ISOFAC), which goes out and picks up samples for testing. The ISOFAC team also brings Soldiers food and picks them up from their respective training site.

The team deployed with a truck that is normally designed to test chemical and biological warfare. They can set up anywhere in the field and run 24-hour missions if necessary.

All of the equipment necessary for COVID-19 testing along with a communications suite for sending out immediate test results is located inside of the truck. Live COVID samples can be opened and tested safely inside the “glove box” of the truck.

“It’s very interesting to be in the middle of it [the COVID-19 pandemic],” concluded Army Capt. Shawna So, chemical officer, assigned to the 773rd Civil Support Team, 7th Mission Support Command. “I think COVID kinda threw things sideways for everybody but to have this new mission set has been amazing.”


As the only U.S. Army Reserve forward stationed command in Europe, nearly 400 soldiers from the 7th Mission Support Command are participating in DEFENDER-Europe 21 to provide planning and support in a variety of specialties: security, coordination, medical, transportation, civil affairs, CBRN and liaisons.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3
Refine your search
Last Updated: June 08, 2021
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery